Osteoporosis and atherosclerosis: Biological linkages and the emergence of dual-purpose therapies

125Citations
Citations of this article
60Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Osteoporosis and atherosclerosis are both widely prevalent in an ageing population, and induce serious morbidities and death. There is growing evidence that in addition to their relationship to ageing, osteoporosis and atherosclerosis are also linked by biological associations. This article reviews their clinical interrelations, discusses the basic biology of bone and the arterial wall, and presents five examples that illustrate their biological linkages. Current therapeutic approaches emerging from these linkages, including statins, bisphosphonates, and the thiazolidinediones, have dual effects on bone and the vasculature. Additional therapies derived from experimental studies that enhance bone density and reduce atherogenesis hold further promise to diminish the morbidity and mortality of osteoporosis and atherosclerosis, with attendant benefits to society. © The Author 2005. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved.

Cite

CITATION STYLE

APA

Hamerman, D. (2005). Osteoporosis and atherosclerosis: Biological linkages and the emergence of dual-purpose therapies. QJM: An International Journal of Medicine. Oxford University Press. https://doi.org/10.1093/qjmed/hci077

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free